JP2023156365A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023156365A5 JP2023156365A5 JP2023122299A JP2023122299A JP2023156365A5 JP 2023156365 A5 JP2023156365 A5 JP 2023156365A5 JP 2023122299 A JP2023122299 A JP 2023122299A JP 2023122299 A JP2023122299 A JP 2023122299A JP 2023156365 A5 JP2023156365 A5 JP 2023156365A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- protein
- linker
- fusion protein
- nuclear localization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806708P | 2019-02-15 | 2019-02-15 | |
| US62/806,708 | 2019-02-15 | ||
| JP2021547390A JP2022520104A (ja) | 2019-02-15 | 2020-02-13 | Ｃｒｉｓｐｒ／ｃａｓ融合タンパク質およびシステム |
| PCT/US2020/018145 WO2020168102A1 (en) | 2019-02-15 | 2020-02-13 | Crispr/cas fusion proteins and systems |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547390A Division JP2022520104A (ja) | 2019-02-15 | 2020-02-13 | Ｃｒｉｓｐｒ／ｃａｓ融合タンパク質およびシステム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023156365A JP2023156365A (ja) | 2023-10-24 |
| JP2023156365A5 true JP2023156365A5 (https=) | 2024-04-26 |
Family
ID=70166116
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547390A Pending JP2022520104A (ja) | 2019-02-15 | 2020-02-13 | Ｃｒｉｓｐｒ／ｃａｓ融合タンパク質およびシステム |
| JP2023122299A Pending JP2023156365A (ja) | 2019-02-15 | 2023-07-27 | Ｃｒｉｓｐｒ／ｃａｓ融合タンパク質およびシステム |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547390A Pending JP2022520104A (ja) | 2019-02-15 | 2020-02-13 | Ｃｒｉｓｐｒ／ｃａｓ融合タンパク質およびシステム |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10947517B2 (https=) |
| EP (1) | EP3924475A1 (https=) |
| JP (2) | JP2022520104A (https=) |
| KR (1) | KR20210139271A (https=) |
| CN (1) | CN113728099A (https=) |
| AU (2) | AU2020221274B2 (https=) |
| BR (1) | BR112021016019A2 (https=) |
| CA (1) | CA3129835A1 (https=) |
| IL (1) | IL285300A (https=) |
| SG (1) | SG11202108812SA (https=) |
| WO (1) | WO2020168102A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| CA3129835A1 (en) | 2019-02-15 | 2020-08-20 | Sigma-Aldrich Co. Llc | Crispr/cas fusion proteins and systems |
| JP2024533311A (ja) * | 2021-09-08 | 2024-09-12 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | ゲノムを調節するための方法及び組成物 |
| CN116063546B (zh) * | 2021-10-29 | 2026-01-16 | 中科辅酶医科技(深圳)有限公司 | 一种基于共振能量转移的全遗传编码nad+蛋白探针及其制备方法和应用 |
| US20230265405A1 (en) * | 2022-02-22 | 2023-08-24 | Massachusetts Institute Of Technology | Engineered nucleases and methods of use thereof |
| JP2025510574A (ja) * | 2022-03-08 | 2025-04-15 | ウェイク・フォレスト・ユニバーシティ・ヘルス・サイエンシーズ | 真核生物遺伝子編集のための組成物、システムおよび方法 |
| WO2025221793A1 (en) * | 2024-04-16 | 2025-10-23 | Monsanto Technology Llc | Modified cas proteins for nuclear localization and editing activity in plants |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030232430A1 (en) | 2001-11-26 | 2003-12-18 | Advanced Cell Technology | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| EP3241902B1 (en) | 2012-05-25 | 2018-02-28 | The Regents of The University of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| EP3363902B1 (en) * | 2012-12-06 | 2019-11-27 | Sigma Aldrich Co. LLC | Crispr-based genome modification and regulation |
| WO2014186686A2 (en) * | 2013-05-17 | 2014-11-20 | Two Blades Foundation | Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases |
| CA2915296A1 (en) * | 2013-06-11 | 2015-02-26 | Portage Pharmaceuticals Ltd. | Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides |
| JP6793547B2 (ja) * | 2013-12-12 | 2020-12-02 | ザ・ブロード・インスティテュート・インコーポレイテッド | 最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物 |
| DK3107562T3 (da) | 2014-02-19 | 2019-12-16 | Bioasis Technologies Inc | P97-ids-fusionsproteiner |
| US11242525B2 (en) | 2014-03-26 | 2022-02-08 | Editas Medicine, Inc. | CRISPR/CAS-related methods and compositions for treating sickle cell disease |
| WO2016054326A1 (en) | 2014-10-01 | 2016-04-07 | The General Hospital Corporation | Methods for increasing efficiency of nuclease-induced homology-directed repair |
| WO2016210271A1 (en) | 2015-06-24 | 2016-12-29 | Sigma-Aldrich Co. Llc | Cell cycle dependent genome regulation and modification |
| JP6867689B2 (ja) * | 2016-01-29 | 2021-05-12 | 国立大学法人東京工業大学 | Ｃａｓ９−ｇＲＮＡ複合体の細胞核内への導入方法、及び細胞内における標的遺伝子の改変方法 |
| WO2017173004A1 (en) * | 2016-03-30 | 2017-10-05 | Mikuni Takayasu | A method for in vivo precise genome editing |
| WO2017180694A1 (en) | 2016-04-13 | 2017-10-19 | Editas Medicine, Inc. | Cas9 fusion molecules gene editing systems, and methods of use thereof |
| CN107579793A (zh) * | 2016-07-04 | 2018-01-12 | 中兴通讯股份有限公司 | 一种通信网络设备间时间同步的优化方法、装置及设备 |
| KR102547316B1 (ko) * | 2016-08-03 | 2023-06-23 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| EP3526320A1 (en) * | 2016-10-14 | 2019-08-21 | President and Fellows of Harvard College | Aav delivery of nucleobase editors |
| JP7182545B2 (ja) | 2016-12-14 | 2022-12-02 | ヴァーヘニンゲン ユニヴェルシテット | 熱安定性ｃａｓ９ヌクレアーゼ |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| KR20200036912A (ko) | 2017-07-31 | 2020-04-07 | 리플렉션 바이오테크놀러지스 리미티드 | 안과 질환을 위한 세포 모델 및 치료요법 |
| US11071791B2 (en) * | 2018-01-26 | 2021-07-27 | Wisconsin Alumni Research Foundation | Vector for gene silencing and replacement and methods of use thereof |
| CN111902536B (zh) | 2018-02-15 | 2024-07-30 | 西格马-奥尔德里奇有限责任公司 | 用于真核基因组修饰的改造的cas9系统 |
| PL3765615T3 (pl) * | 2018-03-14 | 2023-11-13 | Arbor Biotechnologies, Inc. | Nowe enzymy i układy crispr ukierunkowane na dna |
| CA3129835A1 (en) | 2019-02-15 | 2020-08-20 | Sigma-Aldrich Co. Llc | Crispr/cas fusion proteins and systems |
-
2020
- 2020-02-13 CA CA3129835A patent/CA3129835A1/en active Pending
- 2020-02-13 BR BR112021016019-1A patent/BR112021016019A2/pt not_active IP Right Cessation
- 2020-02-13 SG SG11202108812SA patent/SG11202108812SA/en unknown
- 2020-02-13 WO PCT/US2020/018145 patent/WO2020168102A1/en not_active Ceased
- 2020-02-13 EP EP20716979.8A patent/EP3924475A1/en not_active Withdrawn
- 2020-02-13 AU AU2020221274A patent/AU2020221274B2/en not_active Ceased
- 2020-02-13 JP JP2021547390A patent/JP2022520104A/ja active Pending
- 2020-02-13 US US16/790,399 patent/US10947517B2/en active Active
- 2020-02-13 KR KR1020217029732A patent/KR20210139271A/ko not_active Ceased
- 2020-02-13 CN CN202080029346.8A patent/CN113728099A/zh active Pending
-
2021
- 2021-02-10 US US17/172,734 patent/US11965184B2/en active Active
- 2021-08-02 IL IL285300A patent/IL285300A/en unknown
-
2023
- 2023-04-27 US US18/308,336 patent/US20230287377A1/en not_active Abandoned
- 2023-07-27 JP JP2023122299A patent/JP2023156365A/ja active Pending
-
2024
- 2024-04-09 AU AU2024202275A patent/AU2024202275A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023156365A5 (https=) | ||
| IL321024A (en) | Engineered CAS9 Systems For Eukaryotic Genome Modification | |
| US10202619B2 (en) | Compositions and methods directed to CRISPR/Cas genomic engineering systems | |
| CN113373130A (zh) | Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用 | |
| CN113286880A (zh) | 调控基因组的方法和组合物 | |
| FI3765615T3 (fi) | Uusia DNA:han kohdentuvia CRISPR-entsyymejä ja järjestelmiä | |
| JP2011083296A5 (https=) | ||
| JPWO2022056254A5 (https=) | ||
| Perriman et al. | Effective ribozyme delivery in plant cells. | |
| CN101139615A (zh) | 一种快速高效构建哺乳动物细胞rna干扰载体及其验证载体的方法 | |
| JPWO2020181102A5 (https=) | ||
| IL323575A (en) | Isolated nuclease and its use | |
| CN104630229B (zh) | 一种具有启动子功能的dna片段与应用 | |
| CN106086025A (zh) | 一种具有启动子功能的dna片段及其应用 | |
| US5863730A (en) | Procedure for the polymerization of nucleic acid sequences and its applications | |
| US20230235306A1 (en) | Argonaute protein from eukaryotes and application thereof | |
| US9701981B2 (en) | Nucleosome-excluding sequences (NES) as a DNA spacer in vectors results in prolonged transgene expression in eukaryotic cells | |
| CN102296087B (zh) | 基于枯草芽孢杆菌生物素连接酶的外源基因诱导表达调控系统及其构建方法 | |
| WO2022075419A1 (ja) | Ｃｒｉｓｐｒタイプｉ－ｄシステムを利用した標的ヌクレオチド配列改変技術 | |
| JP4665190B2 (ja) | 遺伝子の転写調節方法 | |
| CN121006344B (zh) | 核酸酶TnpB的突变体及其制备方法和应用 | |
| WO2026031760A1 (en) | Isolated nuclease and use thereof | |
| CN114107309B (zh) | 一种非天然茶碱rna分子开关 | |
| JPWO2023039472A5 (https=) | ||
| JP2026074192A (ja) | Ｃｒｉｓｐｒタンパク質をコードする合成自己複製ｒｎａベクターおよびその使用 |